North Staffordshire researchers investigate genetic heart condition ARVC
North Staffordshire researchers received £20,000 in funding from the North Staffordshire Medical Institute to investigate arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart condition associated with abnormal heart rhythms and an increased risk of sudden cardiac death.
The research, led by Dr Vinoj George at Keele University’s Institute for Science and Technology in Medicine, aimed to better understand why the condition can affect patients with very different levels of severity.
By studying the genetic mechanisms behind ARVC, the team hoped its work could eventually contribute to new ways of identifying and controlling the condition earlier in life.
Understanding ARVC
ARVC is a genetic condition that affects the structure and function of the heart muscle.
Mutations affecting proteins that help hold heart muscle cells together can cause cardiac cells to become damaged or die. Over time, this can interfere with the heart’s ability to pump normally and may lead to potentially dangerous irregular heart rhythms.
One of the challenges of ARVC is that people carrying similar genetic mutations can experience very different outcomes. Some may develop significant symptoms, while others can live with the condition for many years with relatively few problems.
Dr George’s research focused on understanding the biological reasons behind these differences.
Using Stem Cells to model Heart Disease
The research team planned to recreate ARVC-associated mutations within human stem cells in the laboratory.
These stem cells could then be developed into cardiac muscle cells, allowing researchers to study how the mutations affected heart tissue under controlled conditions.
The approach enabled the scientists to model aspects of the disease at a cellular level and investigate the genetic factors that might determine whether ARVC became mild or severe.
Exploring genetic triggers
The team also planned to use optogenetic techniques, which use light to influence the activity of cells.
By combining this technology with genetic engineering, researchers hoped to identify genes and cellular mechanisms associated with the severity of ARVC.
Understanding these mechanisms could help provide future targets for medicines or other treatment strategies designed to reduce the impact of the condition.
The longer-term ambition was to translate laboratory discoveries into information that could help clinicians develop more effective approaches to managing patients at risk.
Working towards better treatment strategies
The project also drew on genetic information from patients treated at St George’s Hospital in London, where specialists had experience caring for people with different forms and severities of ARVC.
By comparing laboratory findings with patient data, the researchers hoped to gain a clearer understanding of how particular genetic changes influenced the condition.
Dr George also hoped the findings could ultimately contribute to treatment strategies benefiting patients cared for locally at Royal Stoke University Hospital.
Supporting early-stage medical research
The £20,000 award formed part of the North Staffordshire Medical Institute’s annual research funding programme.
Funding of this kind enables researchers to investigate promising ideas, gather preliminary evidence and develop projects that may later attract larger grants.
The ARVC study demonstrated how charitable support for medical research can help scientists explore complex diseases at their earliest biological stages and work towards new approaches to diagnosis and treatment.
Supporting innovative medical and healthcare research continues to be an important part of the work associated with the Wade Charitable Foundation and North Staffordshire Medical Institute.